Cardiology Medical News about Myocardial Infarction

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death

3. The Job Market for 2008-2009: Compensation

4. Renal Artery Stenosis

5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials
European Heart Journal, 11/02/09

De Luca G et al. – This meta–analysis shows a significant relationship between benefits in mortality from Gp IIb–IIIa inhibitors and patient's risk profile. Thus, Gp IIb–IIIa inhibitors should be strongly considered among high–risk patients.

<< Previous
Ventricular arrhythmia in coronary artery disease: limits of a...

Next >>
HO-1 and CO Decrease Platelet-Derived Growth Factor-Induced...

Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction
Journal of Korean Medical Science, 10/05/09 Relevance Score: 70%

Volumetric Intravascular Ultrasound Analysis of Paclitaxel-Eluting and Bare Metal Stents in Acute Myocardial Infarction. The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Intravascular Ultrasound Substudy
Circulation, 11/02/09 Relevance Score: 69%

The Chemokine Network in Relation to Infarct Size and Left Ventricular Remodeling Following Acute Myocardial Infarction
The American Journal of Cardiology, 10/26/09 Relevance Score: 69%

Clinical Benefit of Early Reperfusion Therapy in Patients With ST-Elevation Myocardial Infarction Usually Excluded from Randomized Clinical Trials (Results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] Registry)
The American Journal of Cardiology, 10/13/09 Relevance Score: 69%

Contribution of angiographic and electrocardiographic parameters of reperfusion to prediction of mortality and morbidity after acute ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial
American Heart Journal, 10/08/09 Relevance Score: 69%